Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine whether sodium oligo-mannurarate capsule is
effective and safe in the treatment of mild to moderate alzheimer' disease, and to determine
the best therapeutic dose of sodium oligo-mannurarate capsule.